Cargando…

Integrative metabolic analysis of orbital adipose/connective tissue in patients with thyroid-associated ophthalmopathy

OBJECTIVE: Thyroid-associated ophthalmopathy (TAO) is a disfiguring autoimmune disease, which destroys the structure of orbital tissues and even threatens vision. Metabolic reprograming is critical in autoimmune diseases; however, the metabolic basis of TAO remains to be clarified. Our study aimed t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Jiancheng, Chen, Meng, Liang, Yu, Hu, Yuxiang, Xia, Weiyi, Zhang, Yihan, Zhao, Chen, Wu, Lianqun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9718489/ https://www.ncbi.nlm.nih.gov/pubmed/36465658 http://dx.doi.org/10.3389/fendo.2022.1001349

Ejemplares similares

Adipose/Connective Tissue From Thyroid-Associated Ophthalmopathy Uncovers Interdependence Between Methylation and Disease Pathogenesis: A Genome-Wide Methylation Analysis
por: Liang, Yu, et al.
Publicado: (2021)

Metabolic features of orbital adipose tissue in patients with thyroid eye disease
por: Du, Rui, et al.
Publicado: (2023)

IL-11 Is Elevated and Drives the Profibrotic Phenotype Transition of Orbital Fibroblasts in Thyroid-Associated Ophthalmopathy
por: Wu, Pengsen, et al.
Publicado: (2022)

Integrative Analysis of Proteomics and DNA Methylation in Orbital Fibroblasts From Graves’ Ophthalmopathy
por: Virakul, Sita, et al.
Publicado: (2021)

Bisphosphonate-Induced Acute Orbital Inflammation in a Patient With Underlying Thyroid Ophthalmopathy
por: Yu, James, et al.
Publicado: (2020)

Treating Thyroid Associated Ophthalmopathy in Pediatric Patients
por: Dong, Tianyu, et al.
Publicado: (2022)

Teprotumumab as a Novel Therapy for Thyroid-Associated Ophthalmopathy
por: Smith, Terry J.
Publicado: (2020)

Dihydroartemisinin Exerts Antifibrotic and Anti-Inflammatory Effects in Graves’ Ophthalmopathy by Targeting Orbital Fibroblasts
por: Yang, Shenglan, et al.
Publicado: (2022)

Therapeutic outcomes of mycophenolate mofetil and glucocorticoid in thyroid-associated ophthalmopathy patients
por: Li, Lan-Fang, et al.
Publicado: (2023)

Increased brain iron in patients with thyroid-associated ophthalmopathy: a whole-brain analysis
por: Hu, Hao, et al.
Publicado: (2023)

Use of Rituximab After Orbital Decompression Surgery in Two Grave’s Ophthalmopathy Patients Progressing to Optic Neuropathy
por: Zhang, Benping, et al.
Publicado: (2020)

Multi-Parametric Diffusion Tensor Imaging of The Optic Nerve for Detection of Dysthyroid Optic Neuropathy in Patients With Thyroid-Associated Ophthalmopathy
por: Liu, Ping, et al.
Publicado: (2022)

Effect of Orbital Decompression on Corneal Topography in Patients with Thyroid Ophthalmopathy
por: Kim, Su Ah, et al.
Publicado: (2015)

Alteration of Connective Tissue Growth Factor (CTGF) Expression in Orbital Fibroblasts from Patients with Graves’ Ophthalmopathy
por: Tsai, Chieh-Chih, et al.
Publicado: (2015)

Potential Therapeutic Activity of Berberine in Thyroid-Associated Ophthalmopathy: Inhibitory Effects on Tissue Remodeling in Orbital Fibroblasts
por: Diao, Jiale, et al.
Publicado: (2022)

Current insights of applying MRI in Graves’ ophthalmopathy
por: Song, Cheng, et al.
Publicado: (2022)

Building the Case for Insulin-Like Growth Factor Receptor-I Involvement in Thyroid-Associated Ophthalmopathy
por: Smith, Terry J., et al.
Publicado: (2017)

Rare Co-occurrence of Ocular Myasthenia Gravis and Thyroid-Associated Orbitopathy (Ophthalmopathy) in an Individual With Hypothyroidism
por: An, Ran, et al.
Publicado: (2019)

Identification of optimal feature genes in patients with thyroid associated ophthalmopathy and their relationship with immune infiltration: a bioinformatics analysis
por: Xiong, Chao, et al.
Publicado: (2023)

Differential Circular RNA Expression Profiling of Orbital Connective Tissue From Patients With Type I and Type II Thyroid-Associated Ophthalmopathy
por: Ye, Huijing, et al.
Publicado: (2022)

Baseline Volumetric T2 Relaxation Time Histogram Analysis: Can It Be Used to Predict the Response to Intravenous Methylprednisolone Therapy in Patients With Thyroid-Associated Ophthalmopathy?
por: Liu, Ping, et al.
Publicado: (2021)

Alterations in Spontaneous Neuronal Activity and Microvascular Density of the Optic Nerve Head in Active Thyroid-Associated Ophthalmopathy
por: Zhu, Pingyi, et al.
Publicado: (2022)

Decreased macular choriocapillaris in thyroid-associated ophthalmopathy: focusing on chorioretinal folds with and without optic disc edema
por: Zeng, Peng, et al.
Publicado: (2023)

Observation study of using a small dose of rituximab treatment for thyroid-associated ophthalmopathy in seven Chinese patients: One pilot study
por: Wang, Yueyue, et al.
Publicado: (2023)

The Unique Metabolic Characteristics of Bone Marrow Adipose Tissue
por: Li, Yujue, et al.
Publicado: (2019)

Cytokines as Targets of Novel Therapies for Graves’ Ophthalmopathy
por: Fallahi, Poupak, et al.
Publicado: (2021)

Results of diplopia and strabismus in patients with severe thyroid ophthalmopathy after orbital decompression
por: Roncevic, Radmilo, et al.
Publicado: (2014)

Tear proteomics of orbital decompression for disfiguring exophthalmos in inactive thyroid-associated ophthalmopathy
por: Jiang, Lihong, et al.
Publicado: (2020)

The outcomes of endoscopic orbital decompression combined with fat decompression for thyroid-associated ophthalmopathy
por: Ye, Yunyan, et al.
Publicado: (2023)

Imaging Evaluation of the Orbit in Graves Ophthalmopathy
por: SAS, T.N., et al.
Publicado: (2015)

Orbital endoscopic decompression in Graves Ophthalmopathy
por: Lima, Wilma Terezinha Anselmo, et al.
Publicado: (2015)

Altered dynamic brain activity and functional connectivity in thyroid‐associated ophthalmopathy
por: Jiang, Wen‐Hao, et al.
Publicado: (2023)

RAGE and HMGB1 Expression in Orbital Tissue Microenvironment in Graves' Ophthalmopathy
por: Łacheta, Dominika, et al.
Publicado: (2021)

Thyroid-associated Ophthalmopathy
por: Şahlı, Esra, et al.
Publicado: (2017)

Brown Adipose Tissue Energy Metabolism in Humans
por: Carpentier, André C., et al.
Publicado: (2018)

MiRNA-21 promotes fibrosis in orbital fibroblasts from thyroid-associated ophthalmopathy
por: Bo-ding, Tong, et al.
Publicado: (2015)

Simvastatin and ROCK Inhibitor Y-27632 Inhibit Myofibroblast Differentiation of Graves’ Ophthalmopathy-Derived Orbital Fibroblasts via RhoA-Mediated ERK and p38 Signaling Pathways
por: Wei, Yi-Hsuan, et al.
Publicado: (2021)

An Interesting Case of Euthyroid Graves’ Ophthalmopathy, With Negative Thyroid-Stimulating Hormone Receptor Antibodies
por: Moeen, Zunera, et al.
Publicado: (2021)

Adipose Tissue Remodeling: Its Role in Energy Metabolism and Metabolic Disorders
por: Choe, Sung Sik, et al.
Publicado: (2016)

Brown Adipose Tissue Heterogeneity, Energy Metabolism, and Beyond
por: Shinde, Abhijit Babaji, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_usr6a6627gkovoau3uf5gt3qrf